IMGN - ImmunoGen, Inc.
Close
31.23
0 0%
Share volume: 0
Last Updated: Fri 09 Feb 2024 10:00:01 PM CET
Pharmaceutical Preparation Manufacturing :
2.72%
PREVIOUS CLOSE
CHG
CHG%
$31.23
0.00
0.00%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-06 | 2022-08-01 | 2022-11-04 | 2023-03-01 | 2023-04-28 | 2023-07-31 | 2023-11-02 | |
| Cash flow financing | 620.000 K | 411.000 K | 449.000 K | 26.074 M | 39.000 K | 437.557 M | 32.132 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -41.402 M | -63.991 M | -64.210 M | -60.199 M | -73.719 M | -66.741 M | 2.770 M | |
| Net income | -24.145 M | -62.021 M | -77.755 M | -59.008 M | -41.014 M | -4.248 M | 30.748 M | |
| Depreciation | 473.000 K | 458.000 K | 424.000 K | 428.000 K | 448.000 K | 427.000 K | 423.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 16.196 M | 614.000 K | 3.233 M | 5.495 M | |
| Changes in receivables | 7.250 M | 5.951 M | 4.191 M | 17.978 M | 31.046 M | 79.964 M | 137.158 M | |
| Investing Cashflow | -307.000 K | -207.000 K | -602.000 K | -248.000 K | -209.000 K | -78.000 K | -1.354 M | |
| Net Borrowings | -449.468 M | -387.973 M | -326.225 M | -286.143 M | -212.204 M | -514.119 M | -552.134 M | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -307.000 K | -207.000 K | -602.000 K | -248.000 K | -209.000 K | -78.000 K | -1.354 M | |
| Cash Change | 437.661 M | 373.874 M | 309.511 M | 275.138 M | 201.249 M | 571.987 M | 605.535 M |